amifostine anhydrous has been researched along with Cancer of Larynx in 2 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral candidiasis is suggested as an objective, early, though indirect, endpoint for amifostine's radioprotective effect on salivary glands." | 2.71 | Oral candidiasis in head and neck cancer patients receiving radiotherapy with amifostine cytoprotection. ( Dardoufas, K; Kolitsi, G; Kouloulias, V; Kyprianou, K; Nicolatou-Galitis, O; Papanikolaou, I; Pissakas, G; Sotiropoulou-Lontou, A; Velegraki, A; Yiotakis, I, 2003) |
| "As for acute xerostomia, patients with laryngeal cancer were excluded from evaluation." | 2.71 | Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer. Is there evidence for radioprotection? ( Fehlauer, F; Feyerabend, T; Hinke, A; Mahlmann, B; Marx, M; Richter, E; Sommer, K; Vacha, P, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nicolatou-Galitis, O | 1 |
| Sotiropoulou-Lontou, A | 1 |
| Velegraki, A | 1 |
| Pissakas, G | 1 |
| Kolitsi, G | 1 |
| Kyprianou, K | 1 |
| Kouloulias, V | 1 |
| Papanikolaou, I | 1 |
| Yiotakis, I | 1 |
| Dardoufas, K | 1 |
| Vacha, P | 1 |
| Fehlauer, F | 1 |
| Mahlmann, B | 1 |
| Marx, M | 1 |
| Hinke, A | 1 |
| Sommer, K | 1 |
| Richter, E | 1 |
| Feyerabend, T | 1 |
2 trials available for amifostine anhydrous and Cancer of Larynx
| Article | Year |
|---|---|
Oral candidiasis in head and neck cancer patients receiving radiotherapy with amifostine cytoprotection.
Topics: Amifostine; Candidiasis, Oral; Female; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Middle | 2003 |
Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer. Is there evidence for radioprotection?
Topics: Amifostine; Antineoplastic Agents; Carboplatin; Combined Modality Therapy; Female; Head and Neck Neo | 2003 |